Spots Global Cancer Trial Database for Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations
Official Title: A Prospective, Randomized, Double-Blinded Control Study of Procrit Versus Placebo to Determine Efficacy in Pre-Operative Patients Undergoing Major Surgical Oncology Operations
Study ID: NCT00624312
Conditions
Study Description
Brief Summary: The purpose of this study is to evaluate the effectiveness of a two-dose regimen of Procrit prior to a major surgical oncology operation.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
University of Louisville, Louisville, Kentucky, United States
Contact Details
Name: Robert Martin, MD
Affiliation: University of Louisville
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
